Up to the day about Atosiban name of the Medicinal product Tractocile 6.75 mg / 0.9 ml solution for injection
DOI:
https://doi.org/10.59843/2618-3692.v17.n29.21715Keywords:
Atosiban, premature birth, nursing, safe administration of medicationsAbstract
Summary: this paper deals with the update of the use of atosiban for the treatment of the threat of preterm birth, using the protocol of administration of Tractocile in the delivery service vs general hospital for its application, for the purpose of systematizing nursing care In the use of this medicine.
Downloads
References
1- European Medicines Agency 2.009. Tractocile atosiban EPAR summary for the public. Acceso junio 2016, disponible en: http://www.ema.europa. eu/docs/en_GB/document_library/EPAR_-_ Summar y _ for _ the _ public/human/000253/ WC500040489.pdf
2- Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) Alerta Farmacéutica R 57/2013 en: www.aemps.gob.es/medicamentosUsoHumano/ portada/home.htm
3- Dirección Nacional de Maternidad e Infancia(2015) Recomendaciones para la prevención, diagnóstico y tratamiento de amenaza de parto pretérmino, atención del parto pretérmino espontáneo y rotura prematura de membranas (2015) Disponible en: http://www.msal.gob.ar/images/stories/bes/graficos/0000000710cnt-guia-parto-pretermino.pdf
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Sanatorio Allende
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Those authors who have published with this journal, accept the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.